About Aditi Pharmaceuticals Pvt Ltd
Data last updated:
Aditi Pharmaceuticals Pvt Ltd is a private limited company based in Solapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN1985PTC036140. Its GSTIN is 27AACCA0728Q1ZG (Maharashtra).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.12 Cr. It is led by directors Atul Shantilal Bakshi (Managing Director) and Jemini Atul Bakshi.
Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E/65/66 MIDC Akkalkot Road, Solapur, Maharashtra, India – 413006.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.54 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹46.46 Lakh (net margin 3.2%) and EBITDA of ₹94.04 Lakh (EBITDA margin 6.5%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The company has about 103 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aditi Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹1.17 Cr on record. Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aditipharma.com.
Company details
CIN history
Aditi Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1985PTC036140. The current CIN is U24239PN1985PTC036140, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239PN1985PTC036140 | Current |
| U24239MH1985PTC036140 | Previous |
Contact details
Aditi Pharmaceuticals Pvt Ltd's registered office is in Solapur, Maharashtra. Its website is aditipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE/65/66 MIDC Akkalkot Road, Solapur, Maharashtra, India – 413006
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aditi Pharmaceuticals operates one associated brand: Aditi Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in contract manufacturing of sterile pharmaceutical products like injections and ampoules. | aditipharma.com |
Business activity
The main business activity of Aditi Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Aditi Pharmaceuticals Pvt Ltd
FY 2025 filings availableAditi Pharmaceuticals Pvt Ltd reported revenue of ₹14.54 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 8% fall in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94.04 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Aditi Pharmaceuticals Pvt Ltd
Aditi Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jemini Atul Bakshi | Director | 03 Oct 2007 | 19 Years 1 Months | Current |
| Atul Shantilal Bakshi Also directs: Solapur Cetp Akkalkot Road Midc Association | Managing Director | 07 May 1985 | 41 Years 5 Months | Current |
Peer comparison
Aditi Pharmaceuticals Pvt Ltd is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Life Medicare and Biotech Private Limited | ₹14.62 Cr (FY 2025) | 328658.0% | New Delhi, Delhi, India | |||
| Aditi Pharmaceuticals Pvt Ltdthis company | ₹14.54 Cr (FY 2025) | ₹46.46 Lakh | 3.2% | -8.0% | 103 | Solapur, Maharashtra, India |
| Adore Pharmaceuticals Pvt Ltd | ₹14.54 Cr (FY 2024) | 3.0% | Vasai, Maharashtra, India | |||
| Lactonova Nutripharm Private Limited | ₹14.52 Cr (FY 2025) | 28.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Aditi Pharmaceuticals Pvt Ltd is audited by DILIPSHRIDHARSAPATNEKAR for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DILIPSHRIDHARSAPATNEKAR | FY 2022 | 032160 |
Shareholding
The shareholding of Aditi Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Nov 2000 | 90082680 | Maharashtra State Financial Corporation | ₹31.5 Lakh | Satisfied | |
| 31 Mar 1995 | 90082424 | Maharashtra State Financial Corporation | ₹20 Lakh | Satisfied | |
| 04 Jul 1994 | 90093620 | Maharashtra State Financial Corporation | ₹30 Lakh | Satisfied | |
| 09 Sep 1993 | 90084002 | State Bank of India | ₹5 Lakh | Satisfied | |
| 04 Jul 1986 | 90093524 | Maharashtra State Financial Corporation | ₹30 Lakh | Satisfied |
To see the full charge records of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 5 View all charges
Legal cases
Aditi Pharmaceuticals Pvt Ltd has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Revn. Appln. ULP) | Filed against the company by an individual | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Revn. Appln. ULP) | Filed against the company by an individual | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Revn. Appln. ULP) | Filed against the company by an individual | Disposed |
To see the full case history of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aditi Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aditi Pharmaceuticals Pvt Ltd has a workforce of 103 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Aditi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCA0728Q1ZG | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aditi Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Aditi Pharmaceuticals Pvt Ltd has 7 board changes on record since 1985: 2 appointments and 5 cessations. The latest: Supriya Ravindra Moholkar ceased to be Director on 20 Jun 2020.
10 earlier events are in the company report.
Frequently asked questions
Aditi Pharmaceuticals is an active private limited company based in Solapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 1985 (41+ years old) and is registered under CIN U24239PN1985PTC036140.
Aditi Pharmaceuticals has 2 current directors:
- Atul Shantilal Bakshi - Managing Director
- Jemini Atul Bakshi - Director
The latest financial statements of Aditi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aditi Pharmaceuticals is 27AACCA0728Q1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aditi Pharmaceuticals is U24239PN1985PTC036140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aditi Pharmaceuticals has 3 court cases on record: 3 filed against it.
Aditi Pharmaceuticals was incorporated on 07 May 1985, making it 41+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Aditi Pharmaceuticals by revenue are Life Medicare and Biotech Private Limited, Adore Pharmaceuticals Pvt Ltd, Lactonova Nutripharm Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Supriya Ravindra Moholkar ceased to be Director on 20 Jun 2020. Rajeev Walchand Karkamkar ceased to be Director on 30 Aug 2019. Kirti Amoolya Vakil ceased to be Additional Director on 22 Aug 2019. Aditi Pharmaceuticals has 7 board changes on record in total.
Aditi Pharmaceuticals can be reached through the website aditipharma.com. Its registered office is in Solapur, Maharashtra, India.
The registered office of Aditi Pharmaceuticals is at E6566 MIDC Akkalkot Road, Solapur, Maharashtra, India – 413006.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
